Laidlaw Wealth Management »

Ishares Tr genomics immun shares owned by Laidlaw Wealth Management

Quarter-by-quarter ownership of Ishares Tr genomics immun (IDNA) shares owned by Laidlaw Wealth Management from 13F filings

Historical chart of Laidlaw Wealth Management investment in Ishares Tr genomics immun

Tip: Access up to 7 years of quarterly data

All positions including Ishares Tr genomics immun held by Laidlaw Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ishares Tr genomics immun by Laidlaw Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $337k 15k 23.01
2023-09-30 $488k 24k 20.35
2023-06-30 $611k 26k 23.35
2023-03-31 $563k 24k 23.27
2022-12-31 $521k 21k 25.17

More positions owned by Laidlaw Wealth Management

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Select Sector Spdr Tr Technology (XLK)
Adobe Systems Incorporated (ADBE)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Short Treas Bd (SHV)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Tesla Motors (TSLA)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Invesco Exchange Traded Fd T S&p500 Eql Tec (RSPT)
UnitedHealth (UNH)
Vanguard Scottsdale Fds Short Term Treas (VGSH)

View all positions for Laidlaw Wealth Management

Top funds holding Ishares Tr genomics immun

Jane Street
Wharton Business Group
Bank of America Corporation
UBS Group
Royal Bank of Canada
Bsc Private Wealth Management
Commonwealth Equity Services
Advisor Group Holdings
Cora Capital Advisors
Citadel Advisors
Visionary Wealth Advisors
Raymond James Financial Services Advisors
Branch Banking & Trust Company
TCG Advisory Services
PFG Investments

View all funds holding Ishares Tr genomics immun